Search Tag: biotechnology

Executive Health Management

Bio-international-convention-bio-2023

2023 05 Jun

Find Bio International Convention on Social Media  Read more

Executive Health Management

Neuway-pharma-appoints-healthcare-sector-veteran-dr-jacques-mallet-to-its-advisory-board

2022 09 Sep

Dr Jacques Mallet, former SVP of Portfolio Analytics/Corporate Strategy at Sanofi, joins NEUWAY’s Advisory Board as independent member adding in depth expertise in pharma corporate development, financing and clinical affairs  NEUWAY Pharma GmbH, a preclinical-stage biotechnology company specializing in the delivery of innovative biotherapeutic...Read more

Executive Health Management

Relmada-therapeutics-appoints-veteran-john-hixon-as-head-of-commercial

2022 21 Jul

Company Continues Commercial Preparations in Advance of Phase III Clinical Trial Readouts for REL-1017 in Major Depressive Disorder Expected in 2022 Relmada Therapeutics, Inc., a late-stage biotechnology company addressing diseases of the central nervous system (CNS) announced the appointment of John Hixon to a newly created position as Head...Read more

Executive Health Management

Jorge-gomez-joins-moderna-as-chief-financial-officer

2022 11 Apr

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines has announced that Jorge Gomez will join Moderna as Chief Financial Officer, effective Monday, May 9, 2022. He will serve on Moderna's Executive Committee and report to Chief Executive Officer, Stéphane Bancel. "I am pleased to welcome Jorge to Moderna...Read more

Executive Health Management

Bio-international-convention-bio-2022

2022 13 Jun

Find Bio International Convention on Social Media   Read more

Executive Health Management

Herophilus-appoints-brad-savall-ph-d-as-vice-president-and-head-of-chemistry

2022 25 Jan

Industry veteran brings deep experience in neuroscience and design of brain penetrant molecules, including at Janssen (Johnson & Johnson), to neuro drug discovery efforts Herophilus, a leading biotechnology company developing neurotherapeutics to cure complex brain diseases, has announced the appointment of Brad Savall, Ph.D. as the company’s...Read more